Car Sales Still Spe...
Health Care: Drugs
Cleveland BioLabs Inc. (CBLI: NASDAQ)
$2.07 0.80 | 62.99%
06/04/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 8.79M | 15.33M | 14.35M | 4.71M |
| Cost of Sales | -525.51K | -407.29K | -362.14K | -324.00K |
| Gross Operating Profit | 9.32M | 15.74M | 14.71M | 5.03M |
| Selling, General, and Administrative Expenses | 11.11M | 9.93M | 6.40M | 5.89M |
| Research & Development | 22.79M | 16.14M | 14.33M | 13.16M |
| Operating Income before D & A (EBITDA) | -24.58M | -10.33M | -6.02M | -14.02M |
| Depreciation & Amortization | 525.51K | 407.29K | 362.14K | 324.00K |
| Interest Income | 183.66K | 99.11K | 21.69K | 260.00K |
| Other Income - Net | 19.69M | -16.03M | -6.46M | 60.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -5.23M | -26.67M | -12.82M | -14.02M |
| Interest Expense | 0.00 | 0.00 | 1.96K | 0.00 |
| Pre-Tax Income | -5.23M | -26.67M | -12.83M | -14.02M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | -1.22M | -305.81K | 0.00 | 0.00 |
| Net Income From Continuing Operations | -4.01M | -26.37M | -12.83M | -14.03M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -4.01M | -26.37M | -12.83M | -14.03M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -4.01M | -26.37M | -12.83M | -14.03M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-4.01M | -26.37M | -12.83M | -14.03M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -4.01M | -26.37M | -13.44M | -15.21M |
| Basic EPS from Continuing Ops. | -0.12 | -1.01 | -0.82 | -1.13 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.12 | -1.01 | -0.82 | -1.13 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.12 | -1.01 | -0.82 | -1.13 |
| Basic Normalized Net Income/Share | -0.12 | -1.01 | -0.82 | -1.13 |
| EPS fr Continuing Ops. | -0.12 | -1.01 | -0.82 | -1.13 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.12 | -1.01 | -0.82 | -1.13 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.12 | -1.01 | -0.82 | -1.13 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.12 | -1.01 | -0.82 | -1.13 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CBLI
- Portfolio NameUser Type
- Contributor5 Health Care Stocks With U...
- Contributor10 Surging Stocks Most at R...
- UserNEW HOME savings
- UserDan128
- UserJustchattin Portfolio 1
- UserSPQR
- UserPICKIN
- UserTom's picks
- Userboo boo
- UserSrRock33's
Latest CBLI Headlines from TheStreet
- More Biotech Twitter Mailbag: Orexigen, Affymax, YM Bio, Spectrum & More 02.29.12 | 07:02 am
- Cleveland BioLabs Stock Gaps Down On Today's Open (CBLI) 06.17.11 | 11:06 am
- Cleveland BioLabs Stock Gaps Down On Today's Open (CBLI) 05.31.11 | 09:05 am
- Biotech Stock Mailbag: Bio-Hazards 03.25.11 | 07:03 am
- 5 Health Care Stocks With Upside 03.21.11 | 11:03 am
- Surging Stocks Most at Risk of a Decline 10.28.10 | 07:10 am
- Stock Offerings: Digital Realty Trust 06.03.10 | 10:06 am
- Sunesis, Taser: Midday Volume Plays 01.06.10 | 11:01 am
- PharmAthene, ICX Technologies: Midday Volume Plays 12.30.09 | 02:12 pm
- Cleveland BioLabs Loses Out On Defense Contract 01.04.08 | 09:01 pm
Press Releases for CBLI
- Mintz Levin Represents Cleveland Biolabs, Inc. In $8.4 Million Direct Offering - Business Wire 01.04.11 | 09:01 am
Partner Headlines for CBLI
- Morning Market Movers - Benzinga 06.04.12 | 09:06 am
- Ultimate Market Recap: Medtox Makes Good, BofA Holds Out on Shareholders - Wall St. Cheat Sheet 06.04.12 | 07:06 am
- 3 Stocks Illuminating Green on a Red Trading Day - Wall St. Cheat Sheet 06.04.12 | 02:06 am
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Rodman & Renshaw Lower Cleveland BioLabs PT to $8 - Benzinga 06.27.11 | 04:06 pm
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 06.20.11 | 09:06 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- Company News for March 16, 2011 - Corporate Summary - Zacks 03.16.11 | 10:03 am
- Morning Market Movers (SSFN, BWEN, ZNWAW, CBLI) - Benzinga 03.15.11 | 09:03 am
- Friday Options Recap - Seeking Alpha 03.11.11 | 04:03 pm
